Welcome to the Allergy Therapeutics Investor Relations Centre.

"We continue to execute our strategy to create significant value for our shareholders."

Manuel Llobet - CEO
Interim results for year ending 31 December 2020

The Interim results for year ending 31 December 2020 will be announced on 3 March 2021

Annual Report 2020